In addition, preventive approaches to diabetic cataracts include AR inhibitors, glycation inhibitors, and antioxidants, but none of these drugs has yet been formulated to offer a fundamental treatment 58,59,60
As people age, the production of hyaluronic acid decreases, leading to drier and less elastic skin
Orforglipron represents a potential new therapeutic option for individuals with type 2 diabetes considering initiation of GLP-1 receptor agonist therapy who might prefer an alternative to the subcutaneous route of administration, Julio Rosenstock, MD, FACE, senior scientific advisor for Velocity Clinical Research, director of Velocitys site at Medical City Dallas and clinical professor of medicine at the University of Texas Southwestern Medical Center, and colleagues wrote
GLP-1 drugs work on both your gut and brain: Slows down digestion, so you feel full for longer